Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-24

Clinical Trial Update: Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing whether tizanidine reduces postoperative urinary retention after sacrospinous vaginal vault suspension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIZANIDINE (TIZANIDINE)

Snippet

Sponsor: Endeavor Health | Conditions: Postoperative Urinary Retention, Sacrospinous Vaginal Vault Suspension | Phase 3 | Status: COMPLETED | Results posted: 2025-11-24